Embecta Corp.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Devdatt Kurdikar
- Full Time Employees
- 1,850
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 300 Kimball Drive Parsippany NJ United States of America 07054
- IPO Date
- Mar 22, 2022
- CIK
- 0001872789
- Website
- embecta.com
- Similar Companies
- Business
- Embecta Corp. (Nasdaq: EMBC), a global medical device company focused on diabetes care solutions, designs, manufactures and markets insulin delivery products including pen needles, syringes, safety injection devices; digital applications such as the BD Diabetes Care app for patient management; and innovative technologies like patch pump systems, primarily sold to wholesalers, distributors, pharmacies and healthcare providers serving people living with diabetes in over 100 countries. Founded in 1924 and headquartered in Parsippany, New Jersey, the company operates manufacturing facilities in the United States, Ireland and China while maintaining nearly 100 years of expertise spun off from Becton Dickinson in April 2022. Embecta recently strengthened its leadership through a long-range financial plan for fiscal 2025-2028 targeting flat constant currency revenue growth, adjusted operating margins of 28-30% and $600 million in cumulative free cash flow; expanded partnerships with over 30 generic GLP-1 companies for pen needle co-packaging and supply including purchase orders and regulatory submissions; committed to expanded humanitarian efforts with Direct Relief through 2026 for pen needle and syringe access following a July 2025 Texas grant; and reported fiscal 2025 fourth quarter results with Q3 revenue near $296 million amid ongoing transition to growth and diversification including GLP-1 opportunities and debt reduction.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Embecta Corp. of Class Action Lawsuit and Upcoming Deadlines – EMBC
Deadline Alert: Embecta Corp. (EMBC) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Bronstein, Gewirtz & Grossman LLC Urges Embecta Corp. Investors to Act: Class Action Filed Alleging Investor Harm
EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with the Schall Law Firm
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 17, 2026 in Embecta Corp. Lawsuit - EMBC
Kaplan Fox Encourages Investors of Embecta Corp. (EMBC) Who Suffered Losses to Contact the Firm Before August 17, 2026
Lawsuit Notice: $EMBC Legal News: Embecta Insulin Pen Issues and 57% Stock Drop Trigger Securities Fraud Class Action
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Embecta Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EMBC
EMBC EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Embecta Investors of Securities Class Action Lawsuit Deadline on August 17, 2026
Bronstein, Gewirtz & Grossman LLC Urges Embecta Corp. Investors to Act: Class Action Filed Alleging Investor Harm
Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business -- HBSS
Levi & Korsinsky Reminds Embecta Corp. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 17, 2026 - EMBC
$EMBC Legal News: Embecta Accused of Misrepresentations about its Insulin Pens in Securities Fraud Class Action – Investors Notified to Contact BFA Law
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Embecta Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EMBC
ROSEN, NATIONALLY REGARDED TRIAL ATTORNEYS, Encourages Embecta Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EMBC
EMBC SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Embecta Investors of Securities Class Action Lawsuit Deadline on August 17, 2026
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Embecta Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EMBC
DEADLINE ALERT for EMBC, FSLR, GTM, BTU: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
Bronstein, Gewirtz & Grossman LLC Urges Embecta Corp. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC Urges Embecta Corp. Investors to Act: Class Action Filed Alleging Investor Harm